Craig A. Hunter
Eli Lilly and Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Craig A. Hunter.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2015
Michael M. Witte; Norman L. Foster; Adam S. Fleisher; Monique M. Williams; Kimberly A. Quaid; Michael Wasserman; Gail Hunt; J. Scott Roberts; Gil D. Rabinovici; James L. Levenson; Ann Marie Hake; Craig A. Hunter; Luann E. Van Campen; Michael J. Pontecorvo; Helen Hochstetler; Linda B. Tabas; Paula T. Trzepacz
Until recently, estimation of β‐amyloid plaque density as a key element for identifying Alzheimers disease (AD) pathology as the cause of cognitive impairment was only possible at autopsy. Now with amyloid‐positron emission tomography (amyloid‐PET) neuroimaging, this AD hallmark can be detected antemortem. Practitioners and patients need to better understand potential diagnostic benefits and limitations of amyloid‐PET and the complex practical, ethical, and social implications surrounding this new technology. To complement the practical considerations, Eli Lilly and Company sponsored a Bioethics Advisory Board to discuss ethical issues that might arise from clinical use of amyloid‐PET neuroimaging with patients being evaluated for causes of cognitive decline. To best address the multifaceted issues associated with amyloid‐PET neuroimaging, we recommend this technology be used only by experienced imaging and treating physicians in appropriately selected patients and only in the context of a comprehensive clinical evaluation with adequate explanations before and after the scan.
Alzheimers & Dementia | 2015
Craig A. Hunter; Noam Y. Kirson; Urvi Desai; Alice Kate G. Cummings; Douglas Faries; Howard G. Birnbaum
Recent developments in diagnostic technology can support earlier, more accurate diagnosis of non‐Alzheimers disease (AD) dementias.
Alzheimers & Dementia | 2013
Noam Y. Kirson; Craig A. Hunter; Urvi Desai; Alice Kate G. Cummings; Alexandra San Roman; Douglas Faries; Christine Hardwick; Howard G. Birnbaum
American Journal of Geriatric Psychiatry | 2015
Michael M. Witte; Norman L. Foster; Adam S. Fleisher; Monique M. Williams; Kimberly A. Quaid; Michael Wasserman; Gail Hunt; Scott Roberts; Gil D. Rabinovici; James L. Levenson; Ann Marie Hake; Craig A. Hunter; Luann E. Van Campen; Michael J. Pontecorvo; Helen Hochstetler; Paula T. Trzepacz
Archive | 2015
Craig A. Hunter; Noam Y. Kirson; Urvi Desai; Kate G. Cummings; Douglas Faries; Howard G. Birnbaum
Archive | 2015
Michael M. Witte; Norman L. Foster; Adam S. Fleisher; Monique M. Williams; Kimberly A. Quaid; Michael Wasserman; Gail Hunt; J. Scott Roberts; Gil D. Rabinovici; James L. Levenson; Ann Marie Hake; Craig A. Hunter; Luann E. Van Campen; Michael J. Pontecorvo; Helen Hochstetler; Linda B. Tabas; Paula T. Trzepacz
Alzheimers & Dementia | 2014
Michael Happich; Noam Y. Kirson; Urvi Desai; Sarah King; Howard G. Birnbaum; David Price; Mark Belger; Craig A. Hunter; Alan Lenox-Smith; Catherine Reed
Alzheimers & Dementia | 2014
Craig A. Hunter; Noam Y. Kirson; Urvi Desai; Ljubica Ristovska; Alice Kate G. Cummings; Howard G. Birnbaum; Kristin Kahle-Wrobleski; Wenyu Ye; Jeffrey Scott Andrews
Parkinsonism & Related Disorders | 2010
B. Fischer; J. Yui Chan; Craig A. Hunter; M. Yvslaker; J.E. Uptegraw; C. Carlsson; A. Kind; G. Gunter Hunt; S. Asthana; C. Gleason
224412 | 2000
S. Romie; Craig A. Hunter; Kimberly A. Quaid; W. Torres; Martin R. Farlow; L. Walsh
